CN1214248A - Chinese medicine for digestive system diseases - Google Patents
Chinese medicine for digestive system diseases Download PDFInfo
- Publication number
- CN1214248A CN1214248A CN 97108675 CN97108675A CN1214248A CN 1214248 A CN1214248 A CN 1214248A CN 97108675 CN97108675 CN 97108675 CN 97108675 A CN97108675 A CN 97108675A CN 1214248 A CN1214248 A CN 1214248A
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- chinese medicine
- digestive system
- percentage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine includes main recipe comprising red sage, sandalwood, amomum vilosum, Concha arcae and other Chinese medicinal materials as well as supplementary recipe. It is used to treat digestive system diseases comprehensively and radically from stomach, entron, liver, gall and other organs comprising the digestive system. It has obvious, stable and fast cure effect and no poor reaction.
Description
The present invention relates to a kind of Chinese medicine for the treatment of digestive system disease.
At present, the medicine of digestive system disease such as treatment gastrointestinal etc. is more, as: " SANJIU WEITAI, KUAIWEI PIAN, WEIDE rather reach the bismuth aluminate compound, motilium of weisen U, the Germany of Japan etc." but it mostly exists in various degree shortcoming or deficiency, main drawback is: single to the ill, and take stopgap measures and do not control that it is basic, the curative effect instability, do not consolidate, untoward reaction is especially generally all arranged.As " motilium " galactorrhea, The extrapyramidal symptoms, dysequilibrium, infantile convulsion, allergy, menoxenia just arranged, have blood in stool, many untoward reaction such as gynaecomastia, fecal incontinence, " SANJIU WEITAI ", curative effect is not obvious, and symptoms such as clothes backs patient red tongue, Shao Jin often occur, desires to split, deficiency of stomach-YIN.
The objective of the invention is to avoid above-mentioned weak point of the prior art, and a kind of instant effect is provided, stable curative effect, obvious, determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs in many ways, conditioning is fundamentally eliminated pathological factor, the Chinese medicine of the treatment digestive system disease that has no adverse reaction comprehensively.
Purpose of the present invention can reach by following measure:
A kind of Chinese medicine for the treatment of digestive system disease, its special character is, the percentage by weight of this Chinese medicine main formula consists of: Radix Salviae Miltiorrhizae 5.7～18.2, Lignum Santali Albi 1.1～7.4, Fructus Amomi 3.4～6.8, Concha Arcae 11.4～34.1, Concha Ostreae 10.2～34.1, extra large Octopus ocellatus Gray 6.8～13.6, Bulbus Fritillariae Thunbergii 3.4～12.5, Fructus Evodiae 1.1～5.7, Rhizoma Coptidis 2.3～14.8.
The percentage by weight composition of main formula of the present invention also can be: Radix Salviae Miltiorrhizae 15.9～18.2, Lignum Santali Albi 2.3～4.5, Fructus Amomi 4.7～6.8, Concha Arcae 15.9～18.2, Concha Ostreae 15.9～18.2, extra large Octopus ocellatus Gray 10.2～12.5, Bulbus Fritillariae Thunbergii 10.2～12.5, Fructus Evodiae 1.1～3.4, Rhizoma Coptidis 12.5～14.8.
The percentage by weight of main formula of the present invention consists of: Radix Salviae Miltiorrhizae 17.0, Lignum Santali Albi 3.4, Fructus Amomi 6.8, Concha Arcae 17.1, Concha Ostreae 17.0, extra large Octopus ocellatus Gray 11.4, Bulbus Fritillariae Thunbergii 11.4, Fructus Evodiae 2.3, Rhizoma Coptidis 13.6.
Main formula of the present invention also can cooperate with auxilliary square I, and the percentage by weight of this auxilliary square I consists of: Radix Ginseng 3.6～7.2, Rhizoma Atractylodis Macrocephalae (parched) 3.6～10.8, Rhizoma Zingiberis 2.2～7.9, Radix Glycyrrhizae Preparata 1.4～7.2, Ramulus Cinnamomi 2.2～7.2, Polyporus 3.6～7.9, Rhizoma Alismatis 3.6～7.2, Poria 7.2～10.8, Fructus Psoraleae 3.6～7.9, nutmeg 3.6～7.2, Fructus Schisandrae Chinensis 2.2～5.0, Rhizoma dioscoreae (parched) 7.2～21.6, Semen Euryales 7.2～11.5, terminalia flesh 2.2～7.9, Halloysitum Rubrum 7.2～14.4; Described main formula is 1: 1 with the proportioning of auxilliary side.
The percentage by weight composition of the auxilliary square I of the present invention also can be: Radix Ginseng 2.9～4.3, Rhizoma Atractylodis Macrocephalae (parched) 6.5～7.9, Rhizoma Zingiberis 3.6～5.0, Radix Glycyrrhizae Preparata 2.9～4.3, Ramulus Cinnamomi 3.6～5.0, Polyporus 6.5～7.9, Rhizoma Alismatis 6.5～7.9, Poria 6.5～7.9, Fructus Psoraleae 6.5～7.9, nutmeg 3.6～5.0, Fructus Schisandrae Chinensis 3.6～5.0, Rhizoma dioscoreae (parched) 10.1～11.5, Semen Euryales 10.1～11.5, terminalia flesh 6.5～7.9, Halloysitum Rubrum 10.1～11.5.
Main formula of the present invention also can cooperate with auxilliary square II, and the percentage by weight of auxilliary square II consists of: the Radix Astragali 6.4～10.3, Radix Sophorae Flavescentis 1.9～7.1, Radix Polygoni Multiflori Preparata 6.4～19.2, Fructus Corni 1.2～7.1, Semen Coicis 6.4～19.2, Radix Bupleuri 1.9～7.1, Radix Notoginseng 1.0～4.5, the Radix Paeoniae Alba 1.2～7.1, Rhizoma Atractylodis Macrocephalae 1.2～9.6, Fructus Lycii 1.2～10.3, Flos Chrysanthemi Indici 5.8～11.5, Herba Hedyotidis Diffusae 9.0～38.5, Herba Scutellariae Barbatae 5.8～9.6.
The percentage by weight composition of the auxilliary square II of the present invention also can be: the Radix Astragali 9.0～10.3, Radix Sophorae Flavescentis 5.8～7.1, Radix Polygoni Multiflori Preparata 12.2～13.5, Fructus Corni 5.8～7.1, Semen Coicis 9.0～10.3, Radix Bupleuri 5.8～7.1, Radix Notoginseng 3.2～4.5, the Radix Paeoniae Alba 5.8～7.1, Rhizoma Atractylodis Macrocephalae 5.8～7.1, Fructus Lycii 9.0～10.3, Flos Chrysanthemi Indici 5.8～7.1, Herba Hedyotidis Diffusae 9.0～10.3, Herba Scutellariae Barbatae 5.8～7.1.
Main formula of the present invention also can cooperate with auxilliary square III, and the percentage by weight of auxilliary square III consists of: Herba Lysimachiae 7.4～48.3, Radix Polygoni Multiflori 7.4～23.3, Fructus Aurantii 2.9～10.7, Radix Scutellariae 2.9～10.7, the Radix Aucklandiae 1.9～9.7, Fructus Toosendan 2.9～10.7, Spora Lygodii 5.8～11.7, Herba Artemisiae Scopariae 9.7～29.1.
The percentage by weight composition of the auxilliary square III of the present invention also can be: Herba Lysimachiae 28.2～30.1, Radix Polygoni Multiflori 13.6～15.5, Fructus Aurantii 8.7～10.7, Radix Scutellariae 8.7～10.7, the Radix Aucklandiae 1.9～3.9, Fructus Toosendan 8.7～10.7, Spora Lygodii 8.7～10.7, Herba Artemisiae Scopariae 13.6～15.5.
The invention will be further described below in conjunction with specific embodiment:
The present invention executes from digestive system internal organs such as stomach, intestinal, liver, gallbladders and controls, and the multi-flavor medicine share, and forms main formula, and bitter sweet making a concerted effort, simultaneously using both cold and hot drugs can be realized goal of the invention.The different symptoms that concrete manifestation goes out according to the digestive system epileptics is equipped with auxilliary side, determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, and treating both the principal and secondary aspects of a disease, curative effect is better.The percentage by weight of main formula of the present invention consists of: Radix Salviae Miltiorrhizae 5.7～18.2, Lignum Santali Albi 1.1～7.4, Fructus Amomi 3.4～6.8, Concha Arcae 11.4～34.1, Concha Ostreae 10.2～34.1, extra large Octopus ocellatus Gray 6.8～13.6, Bulbus Fritillariae Thunbergii 3.4～12.5, Fructus Evodiae 1.1～5.7, Rhizoma Coptidis 2.3～14.8.
The preferable percentage by weight of main formula of the present invention consists of: Radix Salviae Miltiorrhizae 15.9～18.2, Lignum Santali Albi 2.3～4.5, Fructus Amomi 4.7～6.8, Concha Arcae 15.9～18.2, Concha Ostreae 15.9～18.2, extra large Octopus ocellatus Gray 10.2～12.5, Bulbus Fritillariae Thunbergii 10.2～12.5, Fructus Evodiae 1.1～3.4, Rhizoma Coptidis 12.5～14.8.
The percentage by weight of the preferred embodiment of main formula of the present invention consists of: Radix Salviae Miltiorrhizae 17.0, Lignum Santali Albi 3.4, Fructus Amomi 6.8, Concha Arcae 17.1, Concha Ostreae 17.0, extra large Octopus ocellatus Gray 11.4, Bulbus Fritillariae Thunbergii 11.4, Fructus Evodiae 2.3, Rhizoma Coptidis 13.6.
At the digestive system pathological changes, be aided with the intestinal symptom treatment, the percentage by weight of the auxilliary square I of the present invention consists of: Radix Ginseng 3.6～7.2, Rhizoma Atractylodis Macrocephalae (parched) 3.6～10.8, Rhizoma Zingiberis 2.2～7.9, Radix Glycyrrhizae Preparata 1.4～7.2, Ramulus Cinnamomi 2.2～7.2, Polyporus 3.6～7.9, Rhizoma Alismatis 3.6～7.2, Poria 7.2～10.8, Fructus Psoraleae 3.6～7.9, nutmeg 3.6～7.2, Fructus Schisandrae Chinensis 2.2～5.0, Rhizoma dioscoreae (parched) 7.2～21.6, Semen Euryales 7.2～11.5, terminalia flesh 2.2～7.9, Halloysitum Rubrum 7.2～14.4.
The preferable percentage by weight of the auxilliary square I of the present invention consists of: Radix Ginseng 2.9～4.3, Rhizoma Atractylodis Macrocephalae (parched) 6.5～7.9, Rhizoma Zingiberis 3.6～5.0, Radix Glycyrrhizae Preparata 2.9～4.3, Ramulus Cinnamomi 3.6～5.0, Polyporus 6.5～7.9, Rhizoma Alismatis 6.5～7.9, Poria 6.5～7.9, Fructus Psoraleae 6.5～7.9, nutmeg 3.6～5.0, Fructus Schisandrae Chinensis 3.6～5.0, Rhizoma dioscoreae (parched) 10.1～11.5, Semen Euryales 10.1～11.5, terminalia flesh 6.5～7.9, Halloysitum Rubrum 10.1～11.5.
The percentage by weight of one of most preferred embodiment of the auxilliary square I of the present invention consists of: Radix Ginseng 3.6, Rhizoma Atractylodis Macrocephalae (parched) 7.2, Rhizoma Zingiberis 4.3, Radix Glycyrrhizae Preparata 3.6, Ramulus Cinnamomi 4.3, Polyporus 7.2, Rhizoma Alismatis 7.2, Poria 7.2, Fructus Psoraleae 7.2, nutmeg 4.3, Fructus Schisandrae Chinensis 4.3, Rhizoma dioscoreae (parched) 10.8, Semen Euryales 10.8, terminalia flesh 7.2, Halloysitum Rubrum 10.8.
Main formula of the present invention is advisable with 1: 1 with the proportioning of auxilliary square I, cures mainly that gastrointestinal function is not good, chronic diarrhea, chronic dysentery or just the back is half congealed earlier, also can be used for chronic colitis, early stage colon cancer etc.
At the digestive system pathological changes, be aided with liver's symptom treatment, the percentage by weight of the auxilliary square II of the present invention consists of: the Radix Astragali 6.4～10.3, Radix Sophorae Flavescentis 1.9～7.1, Radix Polygoni Multiflori Preparata 6.4～19.2, Fructus Corni 1.2～7.1, Semen Coicis 6.4～19.2, Radix Bupleuri 1.9～7.1, Radix Notoginseng 1.0～4.5, the Radix Paeoniae Alba 1.2～7.1, Rhizoma Atractylodis Macrocephalae 1.2～9.6, Fructus Lycii 1.2～10.3, Flos Chrysanthemi Indici 5.8～11.5, Herba Hedyotidis Diffusae 9.0～38.5, Herba Scutellariae Barbatae 5.8～9.6.
The preferable percentage by weight of the auxilliary square II of the present invention consists of: the Radix Astragali 9.0～10.3, Radix Sophorae Flavescentis 5.8～7.1, Radix Polygoni Multiflori Preparata 12.2～13.5, Fructus Corni 5.8～7.1, Semen Coicis 9.0～10.3, Radix Bupleuri 5.8～7.1, Radix Notoginseng 3.2～4.5, the Radix Paeoniae Alba 5.8～7.1, Rhizoma Atractylodis Macrocephalae 5.8～7.1, Fructus Lycii 9.0～10.3, Flos Chrysanthemi Indici 5.8～7.1, Herba Hedyotidis Diffusae 9.0～10.3, Herba Scutellariae Barbatae 5.8～7.1.
The percentage by weight of one of most preferred embodiment of the auxilliary square II of the present invention consists of: the Radix Astragali 9.6, Radix Sophorae Flavescentis 6.4, Radix Polygoni Multiflori Preparata 12.8, Fructus Corni 6.4, Semen Coicis 9.6, Radix Bupleuri 6.4, Radix Notoginseng 4.0, the Radix Paeoniae Alba 6.4, Rhizoma Atractylodis Macrocephalae 6.4, Fructus Lycii 9.6, Flos Chrysanthemi Indici 6.4, Herba Hedyotidis Diffusae 9.6, Herba Scutellariae Barbatae 6.4.
Main formula of the present invention is advisable with 1: 1 with the proportioning of auxilliary square II, is used to set upright and the easing the affected liver nourishing the liver strengthening spleen, tonifying kidney, enhance immunity, heat-clearing and toxic substances removing and anticancer etc.Also can be used for the treatment of hepatitis B or other type chronic hepatitis.
At the digestive system pathological changes, be aided with the gallbladder symptom treatment, the percentage by weight of the auxilliary square III of the present invention consists of: Herba Lysimachiae 7.4～48.3, Radix Polygoni Multiflori 7.4～23.3, Fructus Aurantii 2.9～10.7, Radix Scutellariae 2.9～10.7, the Radix Aucklandiae 1.9～9.7, Fructus Toosendan 2.9～10.7, Spora Lygodii 5.8～11.7, Herba Artemisiae Scopariae 9.7～29.1.
The preferable percentage by weight of the auxilliary square III of the present invention consists of: Herba Lysimachiae 28.2～30.1, Radix Polygoni Multiflori 13.6～15.5, Fructus Aurantii 8.7～10.7, Radix Scutellariae 8.7～10.7, the Radix Aucklandiae 1.9～3.9, Fructus Toosendan 8.7～10.7, Spora Lygodii 8.7～10.7, Herba Artemisiae Scopariae 13.6～15.5.
The percentage by weight of the preferred embodiment of the auxilliary square III of the present invention consists of: Herba Lysimachiae 29.1, Radix Polygoni Multiflori 14.6, Fructus Aurantii 9.7, Radix Scutellariae 9.7, the Radix Aucklandiae 2.9, Fructus Toosendan 9.7, Spora Lygodii 9.7, Herba Artemisiae Scopariae 14.6.
Main formula pharmacology analysis of the present invention is as follows:
Radix Salviae Miltiorrhizae: hardship is slightly cold.Blood circulation promoting and blood stasis dispelling, removing heat from blood eliminating carbuncle, nourishing blood to tranquillize the mind.Control menoxenia, amenorrhea due to stagnation of blood, the stasis of blood stagnated and suffered from abdominal pain trusted subordinate's pain, lump in the abdomen puerperal.
Lignum Santali Albi: Xin Wen.Regulate the flow of vital energy and transfer, dispersing cold for relieving pain, the breast abdomen pain and the cold syndrome of the stomach that cure mainly due to the QI stagnated by cold are had a pain diseases such as vomiting clear water.
Fructus Amomi: Xin Wen, removing dampness, circulation of qi promoting, warming middle-JIAO, antiabortive.Cure mainly the disease and the pregnancy reactions of retention of dampness in middle-JIAO and stagnation of QI in spleen and stomach, diseases such as frequent fetal movement.
Concha Arcae: salty flat, expectorant blood stasis dispelling, hard masses softening and resolving.Cure mainly the lump in the abdomen mass in the abdomen, iron, the relieving gastric hyperacidity to alleviate stomachache effect is arranged with the acid regurgitation of can treating for stomachache.
Concha Ostreae: salty, be slightly cold, suppressing the hyperactive liver and subsiding YANG, hard masses softening and resolving is restrained astringent or styptic treatment for spontaneous sweatingly, and this product is mainly used its antacid effect herein, can control hyperchlorhydria, gastric ulcer etc.
The sea Octopus ocellatus Gray: salty and bitter, tepor has astringing to arrest bleeding, the merit of relieving gastric hyperacidity to alleviate stomachache.Cure mainly the stomachache acid regurgitation.
Bulbus Fritillariae Thunbergii: bitter cold, the eliminating stagnation of relieving inflammation or internal heat, solid in the treatment abdomen, fullness in the epigastrium.
Fructus Evodiae: arduous heat, slightly poisonous, tool dispersing cold for relieving pain, the merit of the soothing the liver therapeutic method to keep the adverse QI flowing downwards, dampness.Cure mainly coldness and pain in the epigastrium, the vomiting acid regurgitation.
Rhizoma Coptidis: bitter cold has heat clearing and damp drying, the effect of eliminating fire and detoxication.It is damp and hot to cure mainly gastrointestinal, transfers the thick intestinal of stomach, and beneficial gallbladder is treated aphtha.
The pharmacology analysis of the auxilliary square I of the present invention is as follows:
Radix Ginseng: strongly invigorating primordial QI is arranged, and invigorating the spleen to benefit the lung is used for inappetence, and vomiting is had loose bowels.
Rhizoma Atractylodis Macrocephalae (parched): the merit of air making-up and spleen enlivening dampness diuretic is arranged, be used for weakness of the spleen and stomach, epigastric pain etc.
Rhizoma Zingiberis: the merit of warming middle-JIAO recuperating depleted YANG is arranged, can be used for the gastrointestinal sympotoms caused by cold factors, coldness and pain in the epigastrium, half congealed rush down etc.
Radix Glycyrrhizae Preparata: the intestinal of benefit QI invigorating is arranged, and the merit of relieving spasm to stop pain is used for the gastrointestinal weakness, deficiency of QI in middle-JIAO, anorexia and loose stool etc.
Ramulus Cinnamomi: have the merit of warming the meridian for promoting the flow of YANG QI, be used for heart deficiency of spleen-YANG, retention of water-damp in the body has training to mend the kidney-yang merit of the gate of vitality.
Polyporus: the merit of promoting diuresis to eliminate damp pathogen is arranged, be used for watery diarrhea etc.
Rhizoma Alismatis: the merit of promoting diuresis to eliminate damp pathogen is arranged, be used to have loose bowels etc.
Poria: the merit of the strong intestinal of promoting diuresis to eliminate damp pathogen, control small intestinal absorption function difference and asthenia is unable, diseases such as anorexia and loose stool.
Fructus Psoraleae: the merit of warm intestinal antidiarrheal is used for having loose bowels of deficiency of spleen-YANG and kidneyYANG, cold half congealed rush down etc. of abdomen.
Semen Myristicae: have warming middle-JIAO to promote flow of QI, the merit of relieving diarrhea with astringents is used for incessant chronic diarrhea, stagnation of QI due to deficiency-cold, diseases such as abdominal distention.
Fructus Schisandrae Chinensis: have the merit of antidiarrheal, be used for incessant chronic diarrhea.
Rhizoma dioscoreae (parched): the merit of strong intestinal kidney tonifying is arranged, be used for the effect of antidiarrheal.
Semen Euryales: the merit that has strong intestinal to dry, it is with the passing of time more than to be used for diarrhea due to hypofunction of the spleen, and the merit of strengthening intestinal absorption is arranged.
Terminalia flesh: the merit of astringing intestine to stop diarrhea is arranged, be used for the chronic diarrhea chronic dysentery.
Halloysitum Rubrum: the merit of relieving diarrhea with astringents is arranged, use unconsolidation of lower-JIAO, dysentery is more than, and this product is licked and ended sticking tongue, does not promptly have the nature of just anticipating behind the clothes and controls and let out.
The pharmacology analysis of the auxilliary square II of the present invention is as follows:
The Radix Astragali: set upright QI invigorating, the merit of enhance immunity is used for deficiency of vital energy and physically weak after being ill.
Radix Sophorae Flavescentis: the merit of heat clearing and damp drying diuresis is arranged, be used for the jaundice due to damp and hot, let out hepatitis virus clearly.
Radix Polygoni Multiflori Preparata: enrich and benefit essence and blood is arranged, and the merit of invigorating the liver and kidney is used for the low purgation hepatitis B recuperating medicine of immune function.
Fructus Corni: liver and kidney tonifying is arranged, restrain astringent or styptic treatment for spontaneous sweating merit, secrete essence and set upright, be used for the low purgation hepatitis B recuperating medicine of immune function.
Semen Coicis: the effect of spleen invigorating eliminating dampness by diuresis is arranged, and modern medicine is said virus, and traditional medicine is promptly damp and hot, and this product can be cleared up damp-heat virus, and all hepatitis all can be assisted and be controlled.
Radix Bupleuri: the merit of dispersing the stagnated live-QI to relieve the stagnation of QI is arranged, be used for depression of liver-QI, distending pain over the hypochondrium, it is meritorious that the blocking-up hepatitis B is converted into liver cirrhosis.
Radix Notoginseng: removing stasis to stop bleeding is arranged, and the merit of the analgesic therapy of invigorating blood circulation is used for depression of liver-QI, blood follows not smooth.
The Radix Paeoniae Alba: have the yin fluid astringing of nourishing blood, easing the affected liver to relieve pain, the merit of suppressing liver-YANG is used for disharmony in liver-QI, side of body rib epigastric pain, hepatitis B capable of blocking is converted into liver cirrhosis.
Rhizoma Atractylodis Macrocephalae: the merit of dampness diuretic is arranged, be the important adjuvant for the treatment of the liver disease, but enhance immunity.
Fructus Lycii: the merit of tool nourishing the liver and kidney, all diseases for the treatment of the liver deficiency of the kidney yin, the effect that has enhance immunity to set upright.
Flos Chrysanthemi Indici: the function heat-clearing and toxic substances removing, treating the liver is scorching scorchingly hot effective.
Herba Hedyotidis Diffusae: the merit of clearing away heat-damp and promoting diuresis, removing toxicity for eliminating carbuncles is arranged, can control alimentary tract cancer, the hepatitis B sun is turned out cloudy effectively.
Herba Scutellariae Barbatae: the merit of heat-clearing and toxic substances removing is arranged, can be used for the digestive system carcinoma.
The pharmacology analysis of the auxilliary square III of the present invention is as follows:
Herba Lysimachiae: have relieving stranguria by diuresis, the dehumidifying jaundice eliminating, the merit of removing toxic substances and promoting subsidence of swelling is used for the dampness-heat in the liver and gallbladder jaundice, and the energy of cholagogic and lithagogue is arranged.
Radix Polygoni Multiflori: detoxifcation is arranged, and loosening bowel to relieve constipation can be considered the cleaning husband of intestinal.
Fructus Aurantii: the dispelling the stagnated QI removing food stagnancy is arranged, reduce phlegm, be used for promoting the circulation of QI to alleviate the stagnation in middle-JIAO and remove bloated except that painful abdominal mass.
The Radix Aucklandiae: effect with pain relieving in the circulation of qi promoting accent.The medicine compatibility of this product and clearing away heat-damp and promoting diuresis has and strengthens catharsis and declare ventilation to stagnate and begin brokenly Guan Zhineng.
Fructus Toosendan: the merit of promoting the circulation of QI to relieve pain is arranged, and the side of body rib that is used for irritability stasis or incoordination between the liver and stomach is had a pain.
Radix Scutellariae: heat clearing and damp drying is arranged, and the merit of eliminating fire and detoxication is combined with the effect of function of gallbladder promoting liver heat removing with Herba Artemisiae Scopariae etc.
Spora Lygodii: have the merit of relieving stranguria by diuresis, cooperate with all medicines, but the clear jaundice of function of gallbladder promoting, calculus.
Herba Artemisiae Scopariae: favourable damp and clearing heat, the effect of jaundice eliminating subcutaneous ulcer, and bitter diarrhea falls, function of gallbladder promoting is meritorious.
The Chinese medicine of respectively distinguishing the flavor of that respectively distinguish the flavor of Chinese medicine or its in the main formula of the present invention cooperate with auxilliary side is clean, dry respectively, take by weighing the Chinese medicine of respectively distinguishing the flavor of respectively by prescription, proportioning, mixing is morcelled, cross 80～100 mesh sieves, fully mix, drying obtains medicated powder, be advisable to be loaded in the capsule, also can be made into tablet, water preparation, red ball or other dosage form.
The present invention compared with prior art has following advantage:
In many ways execute from digestive system internal organs such as stomach and intestine, liver and gall and to control, comprehensively conditioning, the multi-flavor medicine share, bitter sweet closing Power, simultaneously using both cold and hot drugs, diagnosis and treatment based on an overall analysis of the illness and the patient's condition is treated both principal and secondary aspect of disease, and fundamentally eliminates pathological factor. Evident in efficacy, steady Fixed, instant effect has no adverse reaction. Make capsule, taking convenience, and avoided Chinese medicine to boil earlier frying in shallow oil, rear lower, The slow fire intense fire is grasped bad and the drawbacks such as forfeiture drug effect.
Claims (9)
1, a kind of Chinese medicine for the treatment of digestive system disease, it is characterized in that, the percentage by weight of this Chinese medicine main formula consists of: Radix Salviae Miltiorrhizae 5.7～18.2, Lignum Santali Albi 1.1～7.4, Fructus Amomi 3.4～6.8, Concha Arcae 11.4～34.1, Concha Ostreae 10.2～34.1, extra large Octopus ocellatus Gray 6.8～13.6, Bulbus Fritillariae Thunbergii 3.4～1 2.5, Fructus Evodiae 1.1～5.7, Rhizoma Coptidis 2.3～14.8.
2, a kind of Chinese medicine for the treatment of digestive system disease as claimed in claim 1, it is characterized in that, its percentage by weight consists of: Radix Salviae Miltiorrhizae 15.9～18.2, Lignum Santali Albi 2.3～4.5, Fructus Amomi 4.7～6.8, Concha Arcae 15.9～18.2, Concha Ostreae 15.9～18.2, extra large Octopus ocellatus Gray 10.2～1 2.5, Bulbus Fritillariae Thunbergii 10.2～1 2.5, Fructus Evodiae 1.1～3.4, Rhizoma Coptidis 12.5～14.8.
3, a kind of Chinese medicine for the treatment of digestive system disease as claimed in claim 2 is characterized in that its percentage by weight consists of: Radix Salviae Miltiorrhizae 17.0, Lignum Santali Albi 3.4, Fructus Amomi 6.8, Concha Arcae 17.1, Concha Ostreae 17.0, extra large Octopus ocellatus Gray 11.4, Bulbus Fritillariae Thunbergii 11.4, Fructus Evodiae 2.3, Rhizoma Coptidis 13.6.
4, a kind of Chinese medicine for the treatment of digestive system disease as claimed in claim 1, it is characterized in that: it also comprises auxilliary side, should consist of by auxilliary square percentage by weight: Radix Ginseng 3.6～7.2, Rhizoma Atractylodis Macrocephalae (parched) 3.6～10.8, Rhizoma Zingiberis 2.2～7.9, Radix Glycyrrhizae Preparata 1.4～7.2, Ramulus Cinnamomi 2.2～7.2, Polyporus 3.6～7.9, Rhizoma Alismatis 3.6～7.2, Poria 7.2～10.8, Fructus Psoraleae 3.6～7.9, nutmeg 3.6～7.2, Fructus Schisandrae Chinensis 2.2～5.0, Rhizoma dioscoreae (parched) 7.2～21.6, Semen Euryales 7.2～11.5, terminalia flesh 2.2～7.9, Halloysitum Rubrum 7.2～14.4; Described main formula is 1: 1 with the proportioning of auxilliary side.
5, a kind of Chinese medicine for the treatment of digestive system disease as claimed in claim 4, it is characterized in that, described auxilliary side's percentage by weight consists of: Radix Ginseng 2.9～4.3, Rhizoma Atractylodis Macrocephalae (parched) 6.5～7.9, Rhizoma Zingiberis 3.6～5.0, Radix Glycyrrhizae Preparata 2.9～4.3, Ramulus Cinnamomi 3.6～5.0, Polyporus 6.5～7.9, Rhizoma Alismatis 6.5～7.9, Poria 6.5～7.9, Fructus Psoraleae 6.5～7.9, nutmeg 3.6～5.0, Fructus Schisandrae Chinensis 3.6～5.0, Rhizoma dioscoreae (parched) 10.1～11.5, Semen Euryales 10.1～11.5, terminalia flesh 6.5～7.9, Halloysitum Rubrum 10.1～11.5.
6, a kind of Chinese medicine for the treatment of digestive system disease as claimed in claim 1 is characterized in that: it also comprises auxilliary side, and its percentage by weight consists of: the Radix Astragali 6.4～10.3, Radix Sophorae Flavescentis 1.9～7.1, Radix Polygoni Multiflori Preparata 6.4～19.2, Fructus Corni 1.2～7.1, Semen Coicis 6.4～19.2, Radix Bupleuri 1.9～7.1, Radix Notoginseng 1.0～4.5, the Radix Paeoniae Alba 1.2～7.1, Rhizoma Atractylodis Macrocephalae 1.2～9.6, Fructus Lycii 1.2～10.3, Flos Chrysanthemi Indici 5.8～11.5, Herba Hedyotidis Diffusae 9.0～38.5, Herba Scutellariae Barbatae 5.8～9.6.
7, a kind of Chinese medicine for the treatment of digestive system disease as claimed in claim 6 is characterized in that described auxilliary side's percentage by weight consists of: the Radix Astragali 9.0～10.3, Radix Sophorae Flavescentis 5.8～7.1, Radix Polygoni Multiflori Preparata 12.2～13.5, Fructus Corni 5.8～7.1, Semen Coicis 9.0～10.3, Radix Bupleuri 5.8～7.1, Radix Notoginseng 3.2～4.5, the Radix Paeoniae Alba 5.8～7.1, Rhizoma Atractylodis Macrocephalae 5.8～7.1, Fructus Lycii 9.0～10.3, Flos Chrysanthemi Indici 5.8～7.1, Herba Hedyotidis Diffusae 9.0～10.3, Herba Scutellariae Barbatae 5.8～7.1.
8, a kind of Chinese medicine for the treatment of digestive system disease as claimed in claim 1, it is characterized in that, it also comprises auxilliary side, and its percentage by weight consists of: Herba Lysimachiae 7.4～48.3, Radix Polygoni Multiflori 7.4～23.3, Fructus Aurantii 2.9～10.7, Radix Scutellariae 2.9～10.7, the Radix Aucklandiae 1.9～9.7, Fructus Toosendan 2.9～10.7, Spora Lygodii 5.8～11.7, Herba Artemisiae Scopariae 9.7～29.1.
9, a kind of Chinese medicine for the treatment of digestive system disease as claimed in claim 8, it is characterized in that, described auxilliary side's percentage by weight consists of: Herba Lysimachiae 28.2～30.1, Radix Polygoni Multiflori 13.6～15.5, Fructus Aurantii 8.7～10.7, Radix Scutellariae 8.7～10.7, the Radix Aucklandiae 1.9～3.9, Fructus Toosendan 8.7～10.7, Spora Lygodii 8.7～10.7, Herba Artemisiae Scopariae 13.6～15.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 97108675 CN1214248A (en) | 1997-10-14 | 1997-10-14 | Chinese medicine for digestive system diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 97108675 CN1214248A (en) | 1997-10-14 | 1997-10-14 | Chinese medicine for digestive system diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1214248A true CN1214248A (en) | 1999-04-21 |
Family
ID=5170609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 97108675 Pending CN1214248A (en) | 1997-10-14 | 1997-10-14 | Chinese medicine for digestive system diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1214248A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1093418C (en) * | 1999-11-02 | 2002-10-30 | 乌力吉 | Oral liquid 'Arula' for treating gastrointestinal disease |
| CN1099883C (en) * | 2000-08-14 | 2003-01-29 | 久美彭措 | Tibeten medicine for treating hepatitis B and its preparation |
| CN1101217C (en) * | 1999-08-25 | 2003-02-12 | 李玉民 | Chinese patent medicine for curing diarrhea |
| CN1294971C (en) * | 2004-04-15 | 2007-01-17 | 朱来明 | 'Niaoduqing' granule taken after being mixed with boiling water for cutting uraemia |
| CN101961455A (en) * | 2010-09-21 | 2011-02-02 | 王兴启 | Traditional Chinese medicine for treating chronic colitis disease |
| CN102240392A (en) * | 2011-07-04 | 2011-11-16 | 王启凌 | Medicament for treating gastropathy |
| CN102578487A (en) * | 2012-03-02 | 2012-07-18 | 万勤劳 | Health care salt black beans containing Chinese herbal medicine formula and production process thereof |
| CN103127439A (en) * | 2011-11-29 | 2013-06-05 | 黄乾印 | Traditional Chinese medicine composition for curing colonitis and enteritis |
| CN103751675A (en) * | 2014-01-27 | 2014-04-30 | 山东新希望六和集团有限公司 | Medicine for treating pig dyspepsia and preparation method thereof |
| CN106562997A (en) * | 2016-11-23 | 2017-04-19 | 岑立君 | Composition and preparation method of effective spurrite medicine |
-
1997
- 1997-10-14 CN CN 97108675 patent/CN1214248A/en active Pending
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1101217C (en) * | 1999-08-25 | 2003-02-12 | 李玉民 | Chinese patent medicine for curing diarrhea |
| CN1093418C (en) * | 1999-11-02 | 2002-10-30 | 乌力吉 | Oral liquid 'Arula' for treating gastrointestinal disease |
| CN1099883C (en) * | 2000-08-14 | 2003-01-29 | 久美彭措 | Tibeten medicine for treating hepatitis B and its preparation |
| CN1294971C (en) * | 2004-04-15 | 2007-01-17 | 朱来明 | 'Niaoduqing' granule taken after being mixed with boiling water for cutting uraemia |
| CN101961455A (en) * | 2010-09-21 | 2011-02-02 | 王兴启 | Traditional Chinese medicine for treating chronic colitis disease |
| CN102240392A (en) * | 2011-07-04 | 2011-11-16 | 王启凌 | Medicament for treating gastropathy |
| CN103127439A (en) * | 2011-11-29 | 2013-06-05 | 黄乾印 | Traditional Chinese medicine composition for curing colonitis and enteritis |
| CN103127439B (en) * | 2011-11-29 | 2014-05-28 | 黄乾印 | Traditional Chinese medicine composition for curing colonitis and enteritis |
| CN102578487A (en) * | 2012-03-02 | 2012-07-18 | 万勤劳 | Health care salt black beans containing Chinese herbal medicine formula and production process thereof |
| CN102578487B (en) * | 2012-03-02 | 2013-06-05 | 万勤劳 | Health care salt black beans containing Chinese herbal medicine formula and production process thereof |
| CN103751675A (en) * | 2014-01-27 | 2014-04-30 | 山东新希望六和集团有限公司 | Medicine for treating pig dyspepsia and preparation method thereof |
| CN103751675B (en) * | 2014-01-27 | 2015-11-04 | 山东新希望六和集团有限公司 | Be used for the treatment of dyspeptic medicine of pig and preparation method thereof |
| CN106562997A (en) * | 2016-11-23 | 2017-04-19 | 岑立君 | Composition and preparation method of effective spurrite medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101642540A (en) | Chinese patent medicine for tranquilizing and allaying excitement | |
| CN101066445A (en) | Chinese medicine prepn for curing gastropathy radically | |
| CN1286490C (en) | anti inflammation decoction for treating morbid leucorrhea, etc. | |
| CN1286518C (en) | Chinese medicinal prescription for treating gastropathy | |
| CN103705843A (en) | Medicine for treating stomach diseases | |
| CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
| CN1310654C (en) | 'Yimu' ointment and preparation method | |
| CN1419927A (en) | Sieral schemes and Chinese medicine preparation for traditional Chinese medicine diagnosis and treatment of nephritis and nephropathy syndrome | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN1214248A (en) | Chinese medicine for digestive system diseases | |
| CN1814208A (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN1686331A (en) | Chinese medicinal composition for treating paradentitis and its preparation method | |
| CN105126043A (en) | Traditional Chinese medicine composition for treating liver cirrhosis and application thereof | |
| CN100548355C (en) | A kind of medicine for the treatment of canine parvovirus disease | |
| CN1686314A (en) | Chinese medicinal preparation for treating cervical vertebra disease | |
| CN1160104C (en) | Pill of tortoise plastron and turtle shell | |
| CN1243561C (en) | Chinese medicine for cancer | |
| CN1140291C (en) | Stone-eliminating Jinyin medicine powder | |
| CN105435125A (en) | Chinese herbal medicine beneficial for upper gastrointestinal cancer postoperative rehabilitation | |
| CN113908244A (en) | A Chinese medicinal composition paste and its preparation method | |
| CN105749173A (en) | Drug for treating cirrhosis and preparation method thereof | |
| CN106110169A (en) | The Chinese medicine composition for the treatment of flatulence pain | |
| CN1291504A (en) | Medicine for treating cirrhosis ascites | |
| CN104888093A (en) | Infantile diarrhea treatment umbilical paste | |
| CN103007223A (en) | Traditional Chinese medicine for treating prostatosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |